Literature DB >> 7305440

Polymorphonuclear granulocyte chemotaxis and chemotactic factor generation by concanavalin A-stimulated peripheral blood mononuclear cells in patients with psoriasis.

M Csató, A Dobozy, J Hunyadi, S A Kenderessy, N Simon.   

Abstract

Polymorphonuclear leukocytes from patients with psoriasis demonstrated a significantly enhanced chemotactic responsiveness to zymosan-activated human serum as compared to granulocytes from healthy volunteers. Furthermore, psoriatic peripheral blood mononuclear cells stimulated with concanavalin a produced an increased amount of lymphocyte derived chemotactic factor (LDCF) as compared to that in the case of healthy persons. The LDCF proved to be chemokinetic for the psoriatic granulocyte. It is postulated that these two phenomena may play a role in the pathogenesis of psoriasis.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7305440     DOI: 10.1007/bf00409454

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  15 in total

Review 1.  Immunopathology of psoriasis.

Authors:  S Jablonska; E H Beutner; W L Binder; M Jarzabek-Chorzelska; G Rzesa; O Chowaniec
Journal:  Arch Dermatol Res       Date:  1979-02-23       Impact factor: 3.017

2.  Suppressor function of peripheral blood mononuclear cells in patients with psoriasis vulgaris.

Authors:  J Hunyadi; A Dobozy; A S Kenderessy; N Simon
Journal:  J Invest Dermatol       Date:  1980-09       Impact factor: 8.551

3.  Generation of suppressor cells by concanavalin A: a new perspective.

Authors:  L A Fernandez; J M Macsween
Journal:  J Immunol       Date:  1980-07       Impact factor: 5.422

4.  Polymorphonuclear leukocyte chemotaxis in psoriasis: enhancement by self-activated serum.

Authors:  G Kawohl; B Szperalski; J M Schröder; E Christophers
Journal:  Br J Dermatol       Date:  1980-11       Impact factor: 9.302

5.  Neutrophil chemotaxis in psoriasis.

Authors:  A Wahba; H Cohen; M Bar-Eli; R Callily
Journal:  Acta Derm Venereol       Date:  1979       Impact factor: 4.437

6.  Polymorphonuclear leukocytes: possible mechanism of accumulation in psoriasis.

Authors:  G S Lazarus; F J Yost; C A Thomas
Journal:  Science       Date:  1977-12-16       Impact factor: 47.728

7.  [Leukotactic properties of psoriasis scales].

Authors:  H Langhof; H Müller
Journal:  Hautarzt       Date:  1966-03       Impact factor: 0.751

8.  Leukotactic properties of soluble substances in psoriasis scale.

Authors:  H Tagami; S Ofuji
Journal:  Br J Dermatol       Date:  1976-07       Impact factor: 9.302

9.  Suppressor function of peripheral blood mononuclear cells in normal individuals and in patients with systemic lupus erythematosus.

Authors:  B Bresnihan; H E Jasin
Journal:  J Clin Invest       Date:  1977-01       Impact factor: 14.808

10.  Study of phagocytic function with a quantitative nitroblue-Tetrazolium (NBT) reduction test in diabetes mellitus.

Authors:  M Csató; A Dobozy; N Simon
Journal:  Arch Dermatol Res       Date:  1980       Impact factor: 3.017

View more
  1 in total

1.  Effects of psoriatic sera on the generation of oxygen intermediates by normal polymorphonuclear leucocytes.

Authors:  Y Miyachi; Y Niwa
Journal:  Arch Dermatol Res       Date:  1983       Impact factor: 3.017

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.